Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 690,881 | $ 6,576,232 | $ 1,039,569 | $ 6,576,232 |
| Cost of sales | 414,681 | 7,811,302 | 1,075,619 | 7,811,302 |
| Gross income (loss) | 276,200 | (1,235,070) | (36,050) | (1,235,070) |
| Operating expenses: | ||||
| Operating expenses | 1,574,560 | 2,177,269 | 5,010,244 | 3,724,134 |
| General and administrative expenses | 913,028 | 6,487,895 | 4,883,111 | 10,270,680 |
| Severance expense, net | 13,200,000 | (14,516) | 13,200,000 | |
| Professional fees | 3,544,729 | 11,277,307 | 6,178,735 | 11,853,942 |
| Total operating expenses | 6,032,317 | 33,142,471 | 16,057,574 | 39,048,756 |
| Loss from operations | (5,756,117) | (34,377,541) | (16,093,624) | (40,283,826) |
| Other income (expense) | ||||
| Change in the fair value of notes payable | (188,371) | 4,797,980 | (331,229) | 4,797,980 |
| Change in fair value of warrants | (1,747,324) | 206,166,000 | (6,311,824) | 206,166,000 |
| Loss on issuance of debt to related party | (40,531,000) | (40,531,000) | ||
| ELOC commitment fees | (7,400,000) | (7,400,000) | ||
| Unrealized loss on derivative asset | (16,058,628) | (16,058,628) | ||
| Interest income (expense), net | (6,549,595) | (2,067,970) | (9,633,164) | (3,566,870) |
| Other income (expense), net | 108,389 | (260,732) | 424,407 | (322,748) |
| Total other income (expense) | (8,376,901) | 144,645,650 | (15,851,810) | 143,084,734 |
| Net income (loss) | $ (14,133,018) | $ 110,268,109 | $ (31,945,434) | $ 102,800,908 |
| Income (loss) per common share; basic | $ (0.04) | $ 0.83 | $ (0.11) | $ 0.84 |
| Income (loss) per common share; diluted | $ (0.04) | $ 0.83 | $ (0.11) | $ 0.84 |
| Weighted average number of common shares outstanding; basic | 353,177,339 | 133,638,081 | 297,418,437 | 121,740,904 |
| Weighted average number of common shares outstanding; diluted | 353,177,339 | 133,638,081 | 297,418,437 | 121,740,904 |
| X | ||||||||||
- Definition Change in fair value of note payable. No definition available.
|
| X | ||||||||||
- Definition Loss on issuance of debt to related party. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the fee for available but unused credit capacity under the credit facility. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|